RN

Ronald M. Nordmann

Director at AgeneBio

Ronald M. Nordmann has served as a member of the Board of Directors since September 2013. Mr. Nordmann is a private investor and spent 23 years on Wall Street as a financial analyst, primarily with PaineWebber, Inc., and Oppenheimer & Co., Inc., focusing on the pharmaceutical and biotechnology industries. During his career on the Street, he participated in numerous investment banking transactions. Mr. Nordmann was a partner at Deerfield Management, a healthcare hedge fund. Since retiring in 2000, he devoted his time to corporate governance. Mr. Nordmann sat on the boards of directors of 10 public and private pharmaceutical companies in three countries. Mr. Nordmann is an Emeritus Trustee of Johns Hopkins and sits on the boards of several not-for-profit community organizations including the American Red Cross. He received an undergraduate degree from Johns Hopkins University and an MBA from Fairleigh Dickinson University.